Clinical Trial Update: Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C [NA]

View source ↗

Summary

Clinical trial update regarding pegylated interferon alfa-2a as maintenance therapy for portal hypertension in patients with hepatitis C; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Hepatitis C, Cirrhosis | NA | Status: COMPLETED